chrisvoncsefalvay/vaers-outcomes huggingface dataset:
VIS sheet reviewed with patient who verbalized understanding of side effects. Patient reports never having a previous reaction to any vaccine. Hepatitis B vaccine given IM to left deltoid. Patient administered vaccine at 9:05 am. VS taken at 9:10 am BP 110/60, temp 97.0 pulse 75 respirations 14 patient feels well. 9:12 am patient felt faint, dizzy, flushed. Patient was put in 45 degree angle position with feet up, given cold compress, blood, water, blood glucose taken 118. VS BP 110/60, pulse 50, 97% O2, resps 16 provider notified and evaluated patient, juice given with improvement in symptoms. 9:20 VS BP 110/60, pulse 65, O2 99%, resps 14 patient reported improvement in symptoms. 9:32 BP 90/50, resps 14, O2 97%, pulse 78. 9:36 O2 100%, pulse 69 98/60. Patient monitored for nine minutes. 9:45 patient was cleared by physician to leave office. In reviewing the package insert for ENERGIX: low pulse is a listed reaction. He did not lose consciousness and has never had a vasovagal reaction before. He did have breakfast this am. We monitored him as above and will report the reactions to VAERS. He had not blood sugar issues either. I let him know I would not advise further Hep B vaccines given this reaction. I will let his PCP Dr know what happened.
Supraventricular tachycardia--needing to be seen in ER twice before controlled
Pt developed herpes zoster on her chest. Physician concluded that the herpes zoster and the site of injection were not correlated. Pt did not experience any pain. The herpes zoster was located in the T4-T8 dermatome.
I took the J&J Jansen initial vaccine on April 8th 2021.  This vaccine was the booster shot from Pfizer.  I received the booster on 1-7-2020.  Three days later I woke up and felt extremely dizzy and lite headed.
p/vax pt eyes sl swollen, labored breathing, has history of asthma;started 02 per mask;911 called, vitals taken BP 100/60, P 100, R 24;child crying & congested;pt taken to ER;
Large degree of swelling of left thigh at site of injection accompanied by pain, limp and fever.  Swelling measured ~ 7 x 12 cm 48 hours after vaccine administration, not warm or tender at that time, no fluctuance.
5 cm x 5 cm red/indurated, non tender area right upper thigh.
When drawing up the vaccines, the Rotovirus was drawn up into Pedarix, before it was given to the patient. New vaccines were drawn and given to the patient.
Fluctuant 1.5 cm reddened abscess at right lower deltoid. Moist compress
First dose on 04Mar2021 and Second dose on 22Mar2021; Red Blotchy Rash; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 6204), via an unspecified route of administration in the left arm on 22Mar2021 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, osteoarthritis and asthma. The patient was allergic to penicillin, pecans, bananas and latex. Concomitant medications included methotrexate (MANUFACTURER UNKNOWN), adalimumab (HUMIRA), paracetamol (TYLENOL) and pseudoephedrine hydrochloride (SUDAFED); all from unknown dates for unspecified indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 6202), via an unspecified route of administration in the right arm on 04Mar2021 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Mar2021, the patient experienced red blotchy rash. The patient received first dose on 04Mar2021 and second dose on 22Mar2021 (Inappropriate schedule of vaccine administered). The patient did not receive any treatment for blotchy rash. The clinical outcome of the event red blotchy rash was not recovered and of the inappropriate schedule of vaccine administered was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected
Appendicitis; This is a spontaneous report received from a contactable consumer (patient). A 12-year-old male patient received second dose of BNT162B2 (lot number: EW0202) on 06Jun2021 (at age of 12-year-old) at single dose for COVID-19 immunisation. Medical history included known allergies: Penicillins. Concomitant medications were none. No other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Historical vaccine included first dose of BNT162B2 on unspecified date for COVID-19 Immunization. Patient experienced Appendicitis and appendectomy starting 5 days after 2nd shot (11Jun2021). The evet result in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). Patient was hospitalized for 1 day. Treatment Appendectomy received. The outcome of the event was recovered in Jun2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient had Covid test post vaccination: Nasal Swab on 12Jun2021 with result of negative. The seriousness criteria was reported as Life threatening and Caused/prolonged hospitalization.   Information on lot/batch number has been requested.
Symptoms:  Fever to 101.5, chills, congestion, sneezing, h/a, overall malaise
Patient feels that two weeks after receiving dose #2 she started feeling burning at the injection site which radiates up her arm and causes sever headache. happens multiple times a week. She has a history of migraines but feels this is worse than any headache and it is getting worse
severe pain in left arm/shoulder, unable to move left shoulder for 1 month following vaccination and ongoing.  Frozen shoulder. Currently being treated with steroids orally.  If no response to treatment, may need to see orthopedics for further treatments.
She had a raise in her heart rate; Lips got swollen; Her legs felt like they were sleepy for 4 days; Throat felt tight; This is a spontaneous report from a contactable consumer or other non healthcare professional. A female patient of an unspecified age received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced she had a raise in her heart rate, lips got swollen, her legs felt like they were sleepy for 4 days, throat felt tight. The patient underwent lab tests and procedures which included heart rate raise on unspecified date. The outcome of the events heart rate increased lip swelling, hypoaesthesia, throat tightness was unknown.  No follow-up attempts are possible; Information about Lot/Batch number cannot be obtained.
Complete L arm numbness from shoulder to fingers for 2 hours beginning at 10:00 am the day after administration, then L arm numbness from the shoulder to elbow until 10:00 pm.  Arm was normal except for sore the next morning.
Shakes, redness, throat tightness and itch, given benedryl, and taken to hospital for observation
started feeling faint/feel extremelydizzy and faint/felt some light headedness; This is a spontaneous report received from a contactable consumer (who is also the patient). A 40-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration in the left arm, on 08Apr2021 16:15, as single dose, for COVID-19 immunisation. The patient's medical history was not reported. The patient was not pregnant at the time of vaccination. The patient did not have COVID-10 prior to vaccination and was not tested for COVID-10 post vaccination. Concomitant medication included buprenorphine hydrochloride, naloxone hydrochloride (SUBOXONE); gabapentin; and "plenity" (as reported); all taken for unspecified indications, start and stop dates were not reported. The patient did not receive other vaccines in four weeks. On 08Apr2021 at 16:15, after getting the vaccine, the patient started feeling faint. She continued to feel extremely dizzy and faint for a half hour. She felt some light headedness ever since. The patient did not receive treatment for the event. The patient was recovering from the event.  Information on lot number/batch number has been requested.
Client fainted immediately post vaccination; offered juice and took a few sips, immediately vomited X1 Client was increasingly anxious upon receiving vaccinations and when seeing syringe/needle--encouraged to look other way but still was tense and held breath upon vacination(s) No injury to client as brother was nearby to "catch" client; mother and nurse able to calm client and offer comfort measures such a a cool cloth and resting with family members within reach Client rested quietly sitting in chair for about 10 minutes until color returned to face (pale upon fainting and vomting episode) and able to stand and walk to car with nurse and family members in attendance without further incidence occurring
pt recieved vaccine and after getting up and leaving felt light headed, flushed, red face. had chest pain 911 was called pt left on own.
nausea, syncope sent to ED, not admitted Narrative: 35 yo FEMALE with a history of anaphylaxis to penicillin in her younger years, received her first shot of the Pfizer vaccine earlier today. Approximately 10 minutes after receiving the injection, she felt a sense of lightheadedness, associated with mild nausea, but no shortness of breath or  difficulty swallowing. The next thing she knows, the nurses were standing at her side and she was on the floor. she was seen by the attending staff to look somewhat pale, and have a brief episode of arching of her back before she was lowered to the ground. She did not fall out of the chair onto the ground. There was no subsequent tonic-clonic activity, and the patient did not lose consciousness per the nursing staff in attendance. Concern for the possibility of anaphylaxis the staff administered epinephrine 0.3 mL intramuscular. Upon ED evaluation, the patient appeared to have had a mild vasovagal reaction to her injection. No evidence this was anaphylaxis. A 12-lead EKG was performed which revealed a normal sinus rhythm, with a ventricular rate of 69bpm. Intervals, durations and QRS axis were normal, with no diagnostic ST segments. With further observation there was no concerning symptoms and was discharged home.
Shortly after MMRV was given in Rt thigh, child started complaining ti was hurting and crying and refused to allow any touching or going near to the area. By the evening  area was red. By next day (3/21), injection site redness and swelling was increasing and child refused to allow any one near site. By 5pm 3/21 evening, the site was very red, warm to touch and had lump the size of redness. Site measuring  6.35 cms. By 3/22 7am, affected site had enlarged to  7cms. Child continued to complain of pain and tenderness to touch. Assessment on 3/22 by MD, found also Rt middle ear redness and inflammation. Ear resolved over several days  without antibiotic use, as Rt thigh site resolved.
Chief complaint 30 minutes post injection: I'm itchy? S/S included scalp and facial erythema, scalp, Rt. Arm and hand pruritus and slight anxiety. Denied: SOB, HA, N/V, dizziness, urticarial, abd. Pain, edema to pharynx/tongue/oral cavity/lips, CP or any other complaints besides stated complaint. She was in no obvious distress upon notification of symptoms. VS: 141/71, HR 84R, RR 16 and regular, SPO2 100%, speaking in full sentences with quiet respirations. Referred to local workers' compensation clinic.
Muscle ache Joint ache Vomiting Diarrhea  Hot & cold body temperature: One moment I feel extremely cold and the next moment I might start sweating heavily.  My breathing has gotten worse. It is harder for me to breathe.
grade 2 injection site pain; grade1 injection site swelling; grade 1 fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (grade 2 injection site pain), VACCINATION SITE SWELLING (grade1 injection site swelling) and FATIGUE (grade 1 fatigue) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE PAIN (grade 2 injection site pain), VACCINATION SITE SWELLING (grade1 injection site swelling) and FATIGUE (grade 1 fatigue). On 10-Jan-2021, VACCINATION SITE PAIN (grade 2 injection site pain), VACCINATION SITE SWELLING (grade1 injection site swelling) and FATIGUE (grade 1 fatigue) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
On 3/28/2021 the left side of my face started drooping and I felt slight paralysis.  I went to the doctor 3/29/2021 and was diagnosed with Bells Palsy
GIVEN TO PATIENT OUTSIDE AGE RANGE, DID NOT REPORT ANY ADVERSE EFFECTS, PER MFR MAY NOT BE AS EFFECTIVE AS BOOSTRIX FOR  OVER 64
This spontaneous report as received from a nurse refers to a 20 months 8 days old male patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) LIQUID PEDVAXHIB injection, lot # K016965, exp. date: 20-JUL-2017 (dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaint (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021 at 4:44 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 02-Mar-2021 at 4:44 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 18.13.  Concomitant products were not provided. On 02-Mar-2021, Excursion time was 09 AM, 10 AM, 11 AM, 12 AM, 2 PM, 3 PM. Temperature was 27, 29, 32, 33, 35, 36 respectively. Total doses given for the day was 177 from 9 AM vial. condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 24-Feb-2021, vial was moved to clinic on 02-Mar-2021. 16 vials were sent to clinic. Vaccine BUD date was 26-Mar-2021.  On 02-Mar-2021, vials were stored in cooler 1, at following time and temperature respectively, 8 AM: Not provided, 9 AM: 27, 10 AM: 29, 11 AM: 32, 12 AM: 33, 1PM: 36, 2 PM: 35, 3 PM: 36, 4 PM: 37 and 5 PM: 37.   The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Patient started having feelings of anxiety accompanied by diaphoresis and tingling in extremities.  He sat down to avoid passing out.  No change in diet or other social factors.  Normal life stressors as before.  Receiving deployable immunizations has been the only significant change. Has had 5-6 episodes of anxiety since first onset.  Did not seek out any medical attention until recently coming in to discuss.
Patient phoned health department concerned with complaints of fatigue for 3 days after 2nd Hepatitis A injection with abdominal discomfort 2 days after injection.  Pt also complained of waking up Tuesday, August 19th with approximately 12 5mm sized spots on right side of stomach red in center with pink edges with slight burning.  Denies itching or fever.  Pt concerned that could be possibly related to vaccination or viral. No treatment administered.
fatigue; extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and FATIGUE (extreme fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concomitant products included FLECAINIDE ACETATE, OMEPRAZOLE, ACETYLSALICYLIC ACID (BABY ASPIRIN) and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue) and FATIGUE (extreme fatigue). At the time of the report, FATIGUE (fatigue) and FATIGUE (extreme fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
low fever; diarrea; headache; fatigue; This a spontaneous report received from consumer (patient) via a Pfizer Sponsored program. A female patient of an unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot and expiration date was not reported) via an unspecified route of administration on 23Mar2021 as single dose for COVID-19 immunization. Medical history included acid reflux, other gastrointestinal issues, patient was allergic to bee stings, delayed allergic reaction to codeine medication, allergic to IV contrast, lactose intolerant and can't tolerate dairy products. Concomitant medications were not reported. Patient previously took probiotics, zinc, vitamins and minerals (prior to getting her first dose but would like to know if they interfere with the vaccine). On 23Mar2021, after first dose of vaccine patient experienced low fever, diarrhea, headache, and fatigue. Patient inquired about possible drug interactions between the vaccine and probiotics and vitamins they take for acid reflux and other gastrointestinal issues. Outcome for the events were unknown.  No follow-up attempts are needed. No further information is expected.
When vaccinating the patient the plunger of the syringe got stuck half way through vaccination. The needle was pulled out due to not being able to administer any more. the syringe was placed in a sharps container.
Patient received vaccine. Patient and guardian advised to wait in pharmacy for 15 minutes after vaccination. Guardian (grandmother) declined to wait. Within 10 minutes patient's sister came back to say patient had passed out/blacked out briefly in the front of the check out. Pharmacist found patient to assess. Patient was conscious and sitting down. Sister and grandmother reported patient had fallen suddenly and possibly hit head.  Patient was assessed by pharmacist while EMS was called. Patient reported feeling unwell. Patient was able to drink water and communicate. Patient left with EMS to be assessed at the hospital.
Patient said she had pain at the injection site shortly after the shot. She said that the pain recently stopped in her arm this past week and is now in her shoulder. Patient said she is scheduled to go to her doctor in march.
Covid 12-31-2021 Sore throat, cough,congestion,headache,nausea,diarrhea,fever,fatigue,insomnia,diminished taste and smell, hoarseness
got really sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got really sick) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (got really sick). At the time of the report, ILLNESS (got really sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Chills terrible cold. Headache. And very tired. Slept off an on all day
I had a sore throat, cold, headache, and fatigue. I went to a walk-in clinic, and they prescribed amoxicillin. After a week I still wasn't better, so I went back to the doctor and told me I needed to go the ER. I went to the ER, and they took and X-ray, and diagnosed me with Pneumonia. I was prescribed an antibiotic and a couple other things, but I am unable to recall the names of them. I went back for a checkup, and they did another X-Ray, and they found something on my lung that shouldn't have been there. For some reason I had developed this. I had to have another X-Ray 3 weeks later and this was still there, and they determined it is scar tissue from Pneumonia.
No adverse effects from first vaccination.  Experienced chills, general body aches, headache, and nausea 15 hrs after 2nd vaccination that lasted about  24 hrs.